77. Jahresversammlung der SGIM 2009

Posters


	Schweizerische Gesellschaft für Klinische Pharmakologie und Toxikologie
Rio	Mittwoch, 13. Mai 2009
15.45–17.15	Interaktive Postersession

	Pharmakologie

P178	Daptomycin dosing in patients with continuous veno-venous hemodiafiltration Corti N., Rudiger A., Rentsch K., Maggiorini M. (Zürich)
P179	Measuring the safety profile of drugs Curtin F., Schulz P. (Chêne-Bourg)
P180	Clopidogrel et ritonavir chez un patient HIV, risqué ? Pfaender S., Besson M., Fontana P., Daali Y., Rebsamen M., Junet C., Dayer P., Desmeules J. (Genève)
P181	Serotonin syndrome: presentation of four cases Bertoli R., Bissig M., Pons M., Bernasconi E. (Lugano)
P182	Interaction of NMDA antagonist dextromethorphan and its metabolite with a P-Glycoprotein using an in-vitro model of the human blood-brain barrier Coutisson S., Daali Y., Doffey-Lazeyras F., Gasche Y., Dayer P., Desmeules J. (Genève)
P183	Hematologic, neurologic and renal findings in a case of severe zinc intoxication Beris P., Samii K., Horvath J., Giostra E., Martin P.Y., Burkhard P. (Genève)
P184	Dexamethasone and Risk of Nausea and Vomiting and Post-operative Bleeding After Tonsillectomy in Children: A Randomized Trial Czarnetzki C., Elia N., Lysakowski C., Dumont L., Landis B., Giger R., Dulguerov P., Desmeules J., Tramèr M. (Genève, Sion)
P185	Bisphosphonate and bone safety, a reason to avoid their long term use? Ing Lorenzini K., Peter R., Vogt-Ferrier N., Rollason Gumprecht V., Plachta O., Dayer P., Suva D., Desmeules J. (Genève, Bern)
P186	Predicted and measured CYP2D6 phenotypes in fibromyalgia patients Matthey A., Besson M., Chabert J., Rebsamen M., Daali Y., Piguet V., Rossier M., Dayer P., Desmeules J. (Genève)
P187	Effect of the addition of allopurinol to low dose thiopurines in patients with inflammatory bowel diseases: report of two cases. Curkovic I.M., Ceschi A.E., Fritz D., Rogler G., Kullak-Ublick G.A., Jetter A. (Zürich)
P188	Population pharmacokinetics of valganciclovir in solid organ transplant recipients Buclin T., Csajka C., Lamoth F., Manuel O., Meylan P., Pascual M., Decosterd L., Biollaz J., Buclin T. (Lausanne)
P189	Clinical trials and data safety monitoring boards Rollason V., Chabert J., Irion O., Christoph C., Tramèr M., Dayer P., Desmeules J. (Genève)
P190	Pharmacokinetics and Pharmacodynamics of Nasally Delivered Midazolam Haschke M., Suter K., Hofmann S., Witschi R., Fröhlich J., Imanidis G., Drewe J., Briellmann T., Krähenbühl S., Surber C. (Basel)
P191	Alcohol intoxication at a university emergency departement in Switzerland – with special consideration of young adults aged 16 to 25 years An 8-year observational study Haberkern M., Exadaktylos A., Marty H. (Bern)
P192	Effect of CYP3A4 or CYP2D6 inhibition on the kinetics and dynamics of oxycodone Krähenbühl S., Hammann F., Grignaschi N., Drewe J., Kummer O. (Basel)
P193	A retrospective study of clinical pharmacology consultations evaluating drug-drug interactions in patients treated with acenocoumarol Gschwind L., Vogt-Ferrier N., Bonnabry P., Boehlen F., Rollason Gumprecht V., Besson M., Piguet V., Dayer P., Desmeules J. (Genève, Geneva)
P194	Evaluation of drug-drug interactions with acenocoumarol through data extraction from a computerized physician order entry system Gschwind L., Rollason Gumprecht V., Lovis C., Bonnabry P., Boehlen F., Francis P., Chopard P., Dayer P., Desmeules J. (Genève)